Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
36 hedge funds and large institutions have $2.33M invested in Chembio diagnostics, Inc. in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 11 closing their positions.
16% less funds holding
Funds holding: 43 → 36 (-7)
49% less capital invested
Capital invested by funds: $4.58M → $2.33M (-$2.26M)
54% less call options, than puts
Call options by funds: $53K | Put options by funds: $116K
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$116K |
| 2 |
RPCA
Running Point Capital Advisors
El Segundo,
California
|
+$9.33K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.79K |
| 4 |
Jane Street
New York
|
+$5.51K |
| 5 |
BlackRock
New York
|
+$4.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$281K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$174K |
| 3 |
RA
Royce & Associates
New York
|
-$167K |
| 4 |
PM
Penbrook Management
New York
|
-$105K |
| 5 |
Goldman Sachs
New York
|
-$105K |
CEMI Hedge Fund Activity: Q1 2022 in Review
36 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2022, worth a combined $2.33M — down 49% from $4.58M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CEMI and 4 opened new positions — a net loss of 7 holders — while 17 trimmed existing stakes and 5 added.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $116K. The largest seller was Vanguard Group, cutting an estimated $281K.
- 36 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2022, down from 43 in Q4 2021.
- Funds reported $2.33M of Chembio diagnostics, Inc. stock for Q1 2022, down 49% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q1 2022 and 11 closed out, a net change of -7 holders.
- The largest Chembio diagnostics, Inc. buyer in Q1 2022 was Bank of New York Mellon, an estimated $116K added.
- The largest Chembio diagnostics, Inc. seller in Q1 2022 was Vanguard Group, an estimated $281K sold.
Based on aggregated 13F filings for Q1 2022.